Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today…
Moves into new San Francisco Bay Area R&D facility, comprising approximately 15,700-square-feet of office and lab space, including cGMP-capable manufacturing…
SAN FRANCISCO–(BUSINESS WIRE)–#ai–First paragraph, second sentence of release should read: Recently raising a $5.2M USD series seed co-led by OCA…
In line with anniversary, CHNA ETF completes its semi-annual rebalance LENEXA, Kan.–(BUSINESS WIRE)–$CHNA—The Loncar China BioPharma ETF (Nasdaq: CHNA) today…
New tool empowers patients with direct access point for trial information DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV)…
CTD presentation to take place at the National Niemann-Pick Disease Foundation Conference August 16, 2019 ALACHUA, Fla.–(BUSINESS WIRE)–CTD Holdings, Inc.…
– Quarter marked by reinvigorated focus on purposefully built strategic business units leveraging science-driven cannabinoid research to address areas of…
LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX: BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended June 30, 2019. The Company…